SAN FRANCISCO–(BUSINESS WIRE)–Hagens Berman, a national shareholder rights law firm, is investigating whether Corcept Therapeutics Inc.…
Categoría: Business Wire
Categoría agregada por el Plugin WPeMatico
The Cannabist Company Enters Into Forbearance Agreement With Senior Secured Noteholders
CHELMSFORD, Mass.–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or…
Bitdeer Technologies 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Bitdeer Technologies Group – BTDR
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former…
METC CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Ramaco Resources, Inc. Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class…
AHF Receives Expedited Florida Hearing Opposing ADAP Reductions
Group sued Florida DOH over rules cutting lifesaving HIV/AIDS treatment for thousands FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Today,…
Rayonier and PotlatchDeltic Announce Closing of Merger of Equals
WILDLIGHT, Fla.–(BUSINESS WIRE)–Rayonier (NYSE: RYN) today announced the closing of its merger with PotlatchDeltic Corporation. The…
Inovalis Real Estate Investment Trust Announces Closing of the Disposition of the Trio Property
TORONTO–(BUSINESS WIRE)–Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) announced today that it has completed…
HR Leaders Face Critical Inflection Point as ‘Intentional Organisation’ Becomes Essential for Business Resilience in 2026
New global research from Top Employers Institute reveals that deliberate design will define organisational success in…
Almirall Announces the Approval of Seysara® in China for the Treatment of Moderate-to-Severe Acne
China’s National Medical Products Administration (NMPA) has approved Seysara® (sarecycline hydrochloride) for the treatment of inflammatory…
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% at Actual Exchange Rates (AER);…